Benzinga | Mar 31, 2021 09:30AM EDT

Canaccord Genuity Maintains Hold on AngioDynamics, Raises Price Target to $24

Canaccord Genuity maintains AngioDynamics (NASDAQ:ANGO) with a Hold and raises the price target from $18 to $24.